Dr. David F Hazuka, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 5800 Foxridge Dr, Suite 240, Mission, KS 66202 Phone: 913-261-3153 Fax: 913-262-3295 |
Dr. Richard Cronemeyer, Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 5800 Foxridge Dr, Suite 240, Mission, KS 66202 Phone: 913-261-3153 Fax: 913-262-3295 |
Aaron Michael Lewis, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 5800 Foxridge Dr, Suite 240, Mission, KS 66202 Phone: 913-261-3153 Fax: 913-262-3295 |
Dr. Daniel E Hatfield, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 5800 Foxridge Dr, Ste 240, Mission, KS 66202 Phone: 913-261-3153 |
Craig Matthew Bruner, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 5800 Foxridge Dr, Ste 240, Mission, KS 66202 Phone: 913-261-3153 Fax: 913-262-3295 |
News Archive
A groundbreaking study by two University of Rochester psychologists to be published online Oct. 28 by the Journal of Personality and Social Psychology adds color - literally and figuratively - to the age-old question of what attracts men to women.
Meridian Health Foundation's first annual BuildingHOPE Benefit will take place on Friday, May 13, 2016 at Eagle Oaks Golf & Country Club in Farmingdale, NJ. The event, formerly known as the Sweetheart Ball for its February timeframe, has been moved to May and will benefit oncology research through Meridian Cancer Care.
A new study done by researchers at the University of Delaware and West Chester University of Pennsylvania found that low-income children who take part in reading assistance programs in fifth grade are more depressed, anxious, and withdrawn than their peers, especially when they have chronic reading problems.
When Derrik Neal began having trouble breathing, he initially assumed it was because he was overweight. But after blacking out several times, he learned he had idiopathic pulmonary hypertension. Survival rates at the time he was diagnosed were five years or less - three or less if undetected.
Pharmacyclics LLC today announced interim results from the ongoing Phase Ib/II PCYC-1129 study suggesting that ibrutinib (IMBRUVICA) may be a safe and effective treatment for patients with chronic graft-versus-host-disease (cGVHD) who were either refractory to steroid treatment or were steroid-dependent.
› Verified 3 days ago